
Why Are Bronchogen and Chonluten Compared?
Bronchogen and Chonluten are two short synthetic peptides that appear together in peptide-vendor catalogs and in online short-peptide discussion. Buyers sometimes treat them as near-synonyms because both are marketed as small "bioregulator" peptides with related respiratory-tissue research themes. They are not the same molecule, and ordering one in place of the other can compromise a study. This article compares their reported identity, sequence, molecular parameters and analytical verification requirements.
What Is Bronchogen?
Bronchogen is described as a tetrapeptide. Its sequence is not uniformly recorded:
Commercial database entries (ChemicalBook CBNumber CB93358086) list Ala-Glu-Asp-Leu (AEDL).
The 2011 peer-reviewed DNA-thermostability study (Monaselidze et al., PMID 21240358) uses Ala-Asp-Glu-Leu (ADEL).
Theoretical molecular formula C₁₈H₃₀N₄O₉, molecular weight approximately 446.46 g/mol (identical for both sequence isomers). PubChem lists CAS 857267-12-0 as a synonym for its AEDL Bronchogen record; the ChemicalBook entry leaves CAS blank.
What Is Chonluten?
Chonluten is reported as a tripeptide with the sequence Glu-Asp-Gly (EDG). Its CAS number is 75007-24-8, with molecular formula C₁₁H₁₇N₃O₈ and molecular weight approximately 308.25 g/mol. It is a three-amino-acid peptide - one residue shorter than Bronchogen - and its database sequence record is more consistent across sources. As with Bronchogen, the delivered batch should still be confirmed against its own COA rather than assumed from the trade name.
Key Differences
| Feature | Bronchogen | Chonluten |
|---|---|---|
| Peptide length | Tetrapeptide (4 residues) | Tripeptide (3 residues) |
| Reported sequence | AEDL (commercial record) / ADEL (2011 study) | Glu-Asp-Gly (EDG) |
| Molecular formula (theoretical) | C₁₈H₃₀N₄O₉ | C₁₁H₁₇N₃O₈ |
| Molecular weight (theoretical) | ~446.46 g/mol | ~308.25 g/mol |
| CAS | 857267-12-0 listed for PubChem AEDL record; ChemicalBook blank | 75007-24-8 |
| Sequence consistency | Disputed across sources | More consistent in database record |
| Identity risk | High - sequence order must be confirmed | Moderate - confirm against delivered batch |
Are Bronchogen and Chonluten Interchangeable?
No. They differ in:
- Number of amino acids (4 vs 3), so their molecular weights differ by roughly 138 g/mol.
- Residue composition - Bronchogen includes leucine; Chonluten does not.
- Nominal molecular formula - C₁₈H₃₀N₄O₉ vs C₁₁H₁₇N₃O₈.
A peptide's identity is defined by its full sequence, not by a shared marketing category. Even within Bronchogen itself, AEDL and ADEL are not interchangeable. Within Chonluten, the EDG sequence should also be verified on the batch certificate.
What Does the Published Evidence Actually Show?
- Bronchogen. Monaselidze et al. (2011) reported a DNA-melting-temperature increase of about 3.1 °C in calf-thymus and mouse-liver DNA using differential scanning microcalorimetry. Fedoreyeva et al. (AIMS Biophysics, 2020) examined AEDL in histone binding, chromatin conformation and tobacco (plant) cell experiments.
- Chonluten. Discussed in the same short-peptide bioregulator literature; public evidence is likewise limited to preclinical and in vitro-type observations.
Neither compound has established human clinical efficacy. Both should be treated as research tool compounds, and supplier claims extending the data into therapeutic indications should be read with caution.
How Buyers Can Avoid Peptide Identity Errors
- Write the full sequence on the order. Do not accept "Bronchogen" or "Chonluten" alone as a specification.
- Cross-check molecular weight. Bronchogen ~446.46; Chonluten ~308.25 - a 138 g/mol gap is immediately visible on an LC-MS report.
- Read the COA against the vial. Lot number, product name and sequence must match.
- Request LC-MS identity confirmation. HPLC shows purity; LC-MS shows expected molecular mass.
- Do not substitute based on price or availability. If the supplier cannot confirm the exact sequence, treat the order as unqualified.
FAQ
Is Bronchogen a tetrapeptide?
Yes, reported as four amino acids. Its exact order (AEDL vs ADEL) must be confirmed with the supplier.
Is Chonluten the same as Bronchogen?
No. Chonluten is the tripeptide Glu-Asp-Gly (CAS 75007-24-8); Bronchogen is a tetrapeptide of different composition and mass.
Why do Bronchogen sequences differ across publications?
The commercial record uses AEDL; the 2011 peer-reviewed DNA study uses ADEL. The available records do not prove that every commercial batch carries the same sequence.
How can buyers confirm peptide identity?
Require full sequence on the COA, LC-MS matching the expected mass, HPLC purity with method details, and batch-number traceability.
References
- Monaselidze JR, et al. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability. Bull Exp Biol Med. 2011;150(3):375-377. doi:10.1007/s10517-011-1146-x. PMID: 21240358.
- Fedoreyeva LI, et al. Peptide AEDL alters chromatin conformation via histone binding. AIMS Biophysics. 2020;7(1):1-16.
- ChemicalBook. Bronchogen (Ala-Glu-Asp-Leu), CBNumber CB93358086.
- ChemicalBook. Chonluten CAS 75007-24-8 record.





